Randox Toxicology, UK, introduces three new ELISA testing kits for the detection of sedative drugs Zopiclone, Zaleplon and Zolpidem.
These drugs behave in a similar ways to benzodiazepines, a psychoactive drug which was traditionally used for the treatment of anxiety or insomnia. The Z drugs are found in prescription medications; Lunesta, Ambien, and Sonata, however they should only be used for a short time period as extended use can lead to tolerance.
The misuse of Z drugs is widespread as a result of both dependence and recreational use.
Despite medical advice, many people continue to take these drugs for longer periods than their intended usage; leading to a potential overdose and hazardous consequences. Incidents of unusual or inappropriate behaviour have been linked to misuse of Z drugs, with patients having no memory of their actions. Some users have reported sleepwalking, sleep driving, binge eating, and performing other daily tasks while asleep. These side effects are troubling in a society were sleeping pills have boomed in popularity.
These ELISA kits are for detection of Z drugs in urine and blood specimens.
The Zolpidem ELISA offers Limit of Detection (LOD) of 0.4ng/ml in urine and 0.52ng/ml in blood.
In addition to the Z drug ELISA kits, the company provide a multiplex Biochip Array that targets Zolpidem, Zopiclone, Zaleplon, and their metabolites simultaneously from a single, undivided specimen. The advanced multiplex method consolidates ELISA tests onto a small 9 x 9mm biochip, allowing toxicologists to quickly detect these sedatives.
[Source: Randox Toxicology]